
Alkapac Syrup
MSN LABORATORIES - syrup - 100 ml
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Tapal 50 Tab.
You are viewing
Tapal 50 Tab
tablet - 15 S
₹267
₹17.81 per tablet
MSN LABORATORIES · tablet - 15 S · Rx
₹266
₹17.71 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Tapal 50 Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
Tapentadol (50mg)
Moderate to severe acute pain requiring opioid analgesic treatment (e.g., musculoskeletal pain, postoperative pain) when other analgesics are inadequate.
Tapentadol is a centrally acting opioid analgesic. It works by dual mechanisms: μ-opioid receptor agonism and inhibition of noradrenaline reuptake in the CNS, reducing pain signal transmission and perception.
Take exactly as prescribed by a doctor. Swallow tablet whole with water; can be taken with or without food. Do not crush/chew. Avoid driving or operating machinery after taking; dose and duration depend on pain severity.
Common side effects of Tapal 50 Tab may include:

MSN LABORATORIES - syrup - 100 ml
Standard delivery

MSN LABORATORIES - syrup - 450 ml - 450 ml
Standard delivery

MSN LABORATORIES - tablet - 12.5 mg - 4 S
Standard delivery

MSN LABORATORIES - tablet - 4 S
Standard delivery

MSN LABORATORIES - tablet - 10 Tablet
Standard delivery
MSN LABORATORIES - tablet - 10 Tablet
Standard delivery

MSN LABORATORIES - tablet - 10 S
Standard delivery

MSN LABORATORIES - tablet - 10 S
Standard delivery
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Prescription-only opioid; risk of dependence, abuse and withdrawal. May cause severe drowsiness, respiratory depression and low blood pressure—higher risk in elderly, debilitated, or with lung disease (asthma/COPD). Avoid combining with other CNS depressants. Use caution in head injury/raised intracranial pressure, seizure disorders, liver/kidney impairment. Do not stop abruptly after prolonged use. Not recommended in severe respiratory depression or paralytic ileus. Keep out of reach of children.